Uniphyl: Oral tablet, extended release (400mg)
- Get answers to Frequently Asked Questions (FAQs)
- Find other class related drugs
- Find additional patient usage statistics
Mylan Pharmaceuticals Inc.
Mylan Pharmaceuticals Inc.
Pack Pharmaceuticals, LLC, a subsidiary of Rising Pharmaceuticals
Purdue Frederick Co
Mylan Pharmaceuticals Inc.
What is this Medicine?
THEOPHYLLINE (the OFF i lin) is a bronchodilator. It helps open up the airways in your lungs to make it easier to breathe. This medicine is used to treat the symptoms of asthma, bronchitis, and emphysema.
Similar Generic Drugs : Theophylline, Anhydrous: Oral tablet, extended release (300mg) | Theophylline, Anhydrous: Oral tablet, extended release (100mg) | Theophylline, Anhydrous: Oral tablet, extended release (450mg) | Theophylline, Anhydrous: Oral tablet, extended release (200mg) | Theophylline, Anhydrous: Oral tablet, extended release (400mg)
Uniphyl 400mg Controlled-Release Tablet
NDC: 000347004-
Prescription Required
-
Not a Controlled Drug
(CSA Schedule) -
FDA Approved
Emphysema, Chronic Obstructive Pulmonary Disease (COPD), Asthma, Bronchospasm Prophylaxis
Sometimes used for but not FDA approved for the following conditions:
Sleep Apnea
Protect from light
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Reported Side Effects for Uniphyl 400mg Controlled-Release Tablet
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: EARLY
Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.



Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.
- Get answers to Frequently Asked Questions (FAQs)
- Find other class related drugs
- Find additional patient usage statistics
Be the first to share your experience!
We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.


